It’s been six years since the US Food and Drug Administration issued draft guidances on the use of social media to provide information about prescription drugs, and stakeholders are eager to know when the agency will be providing further advice.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?